Ajinomoto Tai Pei Shrimp Fried Rice Recall Due to Glass Contamination

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Ajinomoto Foods North America Inc. is recalling 118,956 pounds of Tai Pei Shrimp Fried Rice because of potential glass contamination in the product.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on April 7, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, cpsc, Food.

What Happened

Ajinomoto Foods North America Inc. is recalling their Tai Pei Shrimp Fried Rice due to the presence of foreign objects, specifically glass pieces varying in size from 1-3 cm long and 2-4 mm wide.

Which Products Are Affected

The affected product is Item 81146 Ajinomoto Tai Pei Shrimp Fried Rice, which includes shrimp, vegetables, and fried rice with oyster flavored sauce, with a net weight of 48 oz (3 lbs.) per box. Retail box UPC: 070077811465; Case UPC: 10070077811462. The recall involves 9,913 cases totaling 118,956 lbs., packaged as flexible bags in a master case or flexible bags in cartons in a master case, with 4 boxes or 12 lbs. per case. Products have Best By Dates of January 18, 2027; January 21, 2027; February 16, 2027; and March 10, 2027. These were distributed in AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, and WY.

What You Should Do

Consumers who have the affected product should contact Ajinomoto Foods North America Inc. at their address: 4200 Concours Ste 100, Ontario, CA 91764-4982, for instructions on returns or refunds, as this is a voluntary firm-initiated recall.

Why This Matters

The recall addresses a potential hazard from glass in food, which could cause injury if consumed, affecting a significant quantity of product distributed across multiple U.S. states.

Source

FDA Recall Notice: H-0597-2026

Original source: FDA Official Notice ↗

All FDA Recalls →

Nationwide notices with similar length or severity timing 8

Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Ajinomoto Foods North America Inc. is recalling 118,956 pounds of Tai Pei Shrimp Fried Rice because of potential glass contamination in the product.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.